670
Participants
Start Date
December 31, 2011
Primary Completion Date
December 31, 2017
Study Completion Date
December 31, 2017
Ofatumumab
Chlorambucil
Bendamustine
RECRUITING
Countess of Chester Hospital, Chester
RECRUITING
Derriford Hospital, Plymouth
RECRUITING
Torbay Hospital, Torquay
RECRUITING
Royal Bournemouth Hospital, Bournemouth
RECRUITING
Dorset County Hospital, Dorchester
RECRUITING
Colchester General Hospital, Colchester
RECRUITING
Basingstoke and North Hampshire Hospital, Basingstoke
RECRUITING
Southampton General Hospital, Southampton
RECRUITING
Barnet and Chase Farm Hospitals, Enfield
RECRUITING
Kent and Canterbury Hospital, Canterbury
RECRUITING
Maidstone Hospital, Maidstone
RECRUITING
Princess Royal Hospital, Orpington
RECRUITING
Queen Elizabeth Hospital, Woolwich
RECRUITING
West Middlesex University Hospital, Isleworth
RECRUITING
Ealing Hospital, Southall
RECRUITING
Hillingdon Hospital, Uxbridge
RECRUITING
Belfast City Hospital, Belfast
RECRUITING
Royal United Hospital, Bath
RECRUITING
Weston General Hospital, Weston-super-Mare
RECRUITING
Queens Hospital, Burton-on-Trent
RECRUITING
Queen Elizabeth Hospital, Gateshead
RECRUITING
Queen Elizabeth Hospital, Birmingham
RECRUITING
Bradford Royal Infirmary, Bradford
RECRUITING
Airdale General Hospital, Keighley
RECRUITING
St James University Hospital, Leeds
RECRUITING
Salisbury District Hospital, Salisbury
RECRUITING
Arrowe Park Hospital, Upton
RECRUITING
Royal Liverpool Hospital, Liverpool
Collaborators (3)
GlaxoSmithKline
INDUSTRY
Napp Pharmaceuticals Limited
INDUSTRY
Chugai Pharma USA
INDUSTRY
University of Liverpool
OTHER